If you bought $10,000 worth of Kodak stock two days ago, you’d have $150,000 now. You’d also have an arrest warrant pending, but more on that later. The fallen photography giant, Kodak, just became a weird and wonderful vaccine play as it’s taken receipt of a senseless White House loan.
President Trump stood under the sun in the Rose Garden and touted to press that Kodak was the lucky winner of his 765-million-dollar loan prize. If this wasn’t crazy, the stock wouldn’t have soared 500%; markets are not that inefficient. There’s a reason this has never happened before.
If Kodak had a realistic shot at making ingredients profitably in the long run, it would have financed itself with bank loans or share issuances via the stock market. The Trump administration, by definition, is alone in seeing prospects in Kodak, a business with no drug-making expertise.
Kodak has been dead on arrival for some time; look at the five-year chart. It has gone months and months barely mustering any volume (50–200k shares per day), but on Monday, the day before this bizarre Kodak deal was announced, 1.6 million shares changed hands.
The investors with the unbelievable foresight to load up on shares hours before the stock soared up 1,600% deserve plane tickets straight to Omaha. These people need to start funds, write books, offer courses. I’m being sarcastic, of course. It’s blatant fraud. The market can see from Form 4’s submitted to the Securities and Exchange Commission (SEC) that insiders were buying up. Freeze!
I am not a financial advisor and my comments should never be taken as financial advice. Investments come with risk, so always do your research and analysis beforehand.